ParActin® is a patented extract of Andrographis paniculata, standardized to bioactive andrographolides and supported by more than 30 studies, including multiple human clinical trials. It modulates inflammation by inhibiting NF-κB and activating PPAR-gamma, resulting in reduced pro-inflammatory cytokines and improved joint comfort, mobility, and muscle recovery. Clinically studied at 300 mg/day, ParActin® is vegan, allergen-free, and available in organic and conventional forms. Suitable for capsules, tablets, and functional blends, it offers formulators a proven option for joint, bone, immune, and healthy aging applications.